Developer of gene therapies targeting kidney disease.
Founders
Moin Saleem(United Kingdom · ♂)— A world-leading kidney specialist at the University of Bristol, Saleem founded Purespring (launched with Syncona in 2020) to translate his podocyte research into AAV gene therapies delivered directly to the kidney.
Team & hubs
In the network
Shares the most investors with (number = shared investors):